EG665389 inhibitors are a class of chemical compounds that are known for their ability to specifically inhibit the activity of the EG665389 protein or enzyme. These inhibitors generally work by binding to the active site or another functional domain of the protein, preventing its normal biological activity. The structural diversity of EG665389 inhibitors is broad, with many derivatives designed to optimize their binding affinity and specificity to the target protein. Typically, these compounds exhibit a mix of hydrophobic and hydrophilic regions, allowing them to interact with both polar and non-polar residues of the EG665389 protein. The design and synthesis of EG665389 inhibitors involve a thorough understanding of the protein's 3D structure, enabling the formation of potent interactions through hydrogen bonding, van der Waals forces, and sometimes metal coordination complexes. The inhibitory mechanism may vary depending on whether the compound acts as a competitive or non-competitive inhibitor, which influences the degree and nature of their inhibitory effects on the EG665389 protein function.
Chemically, EG665389 inhibitors might incorporate various functional groups, including aromatic rings, amides, heterocycles, and substituents like halogens or nitro groups that enhance their binding properties. They often display selective inhibition, allowing them to specifically target the EG665389 protein while minimizing off-target interactions with other proteins. Advanced molecular modeling and high-throughput screening have facilitated the discovery and optimization of these inhibitors, allowing fine-tuning of their pharmacokinetic and physicochemical properties, such as solubility, stability, and membrane permeability. Furthermore, some EG665389 inhibitors are developed as prodrugs, meaning they are metabolically activated within a biological system to produce an active form that can bind to and inhibit the target protein. Such modifications often enhance bioavailability and improve the compound's overall efficacy as an inhibitor. This chemical class represents an important aspect of molecular chemistry, particularly in understanding protein-ligand interactions and the development of highly selective biochemical modulators.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, thus preventing downstream Akt activation; this inactivation can reduce the phosphorylation and subsequent activity of Gm7616. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, leading to decreased Akt-mediated phosphorylation events that are necessary for Gm7616 activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to and inhibits mTOR, leading to reduced protein synthesis, which includes the synthesis of Gm7616, thereby inhibiting its accumulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1, thereby preventing ERK activation and subsequent phosphorylation of proteins, likely resulting in reduced Gm7616 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which is involved in stress responses that can lead to the activation of Gm7616, thus reducing its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, thereby diminishing AP-1-mediated transcriptional events that could decrease the expression and activity of Gm7616. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibits the 26S proteasome, which may prevent the degradation of inhibitory proteins that bind to and inactivate Gm7616. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Inhibits proteasome activity, potentially leading to the accumulation of proteins that bind and inhibit Gm7616. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Inhibits Src family kinases, leading to reduced activation of downstream targets, which can result in diminished Gm7616 activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits Abl tyrosine kinases, preventing phosphorylation and activation of signaling molecules that may be necessary for Gm7616 activation. | ||||||